Search results for: Health Policy and Regulation
Filter search results
Cost of the NHS
1 October 1978
…than both hospital and community health services. It is forecast that, in the current financial year, the volume outlay on general medical and pharmaceutical services will rise by 2-4 per…
Price Comparisons of Identical Products in Japan, the United States and Europe
1 August 1981
The promotion of an environment in which the multinational research-based pharmaceutical industry can flourish has been and will continue to be reliant upon a well-informed and widely-disseminated understanding of the…
AIDS: Worldwide Policies and Problems
1 September 1991
…presents special problems for prevention and control, as well, of course, as treatment and care. This is a truly international problem, one which has spread because of travel and movements…
Hypothecated Health Taxes: An evaluation of recent proposals
1 January 1995
…of public goods and externalities or as part of an analysis of improvements in the distribution of income. Some economists were interested in political theories of tax and expenditure determination,…
Drivers of the Growth in Medicines Expenditure
1 October 1997
Increases in expenditure on medicines, above the level of increases in health care expenditure generally, are a feature of all Western health systems, including the UK’s. This paper examines the…
Making the best of the Private Finance Initiative in the NHS
1 December 2002
…of Health Economics and ACCA with the Future Healthcare Network of the NHS… This briefing is based on the results of a seminar held in London on 30 May 2002….
The Life Cycle of Pharmaceuticals: A Cross-National Perspective
1 April 2002
…on per capita consumption and hence total expenditures. The life cycle price, volume and expenditure profiles reported here address some of these policy and corporate questions, while also making a…
Health Expenditure in the UK
1 May 1986
Share this: Download publication Robert Chew In the UK in 1984 the combined expenditure on health care services by both the public and private sectors rose to a record total…
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
1 March 2015
…and coverage is limited. In Wales, Scotland and Northern Ireland, lack of hospital prescription data poses an important barrier for the assessment of medicine use by indication, with limited primary…